Company / Inventory per Share
BioMarin Pharmaceutical Inventory per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory per Share
$6.75
FY2025
5-year range
$4.27 / $6.75
FY2021-FY2025
Trend
+4.5%
vs FY2024
Sector context
#11 of 105
Health Care
What the data says
Among 105 Health Care companies, BioMarin Pharmaceutical is in the top 10% for inventory per share. Inventory per Share has increased for 9 consecutive years, from $2.06 in FY2016 to $6.75 in FY2025.
Based on SEC 10-K filings.
6.75 in FY2025 with a 5-year CAGR of +11.9%. Top quartile in the Health Care sector.
Improved from $5.87 to $6.75 over the past 2 years.
Health Care sector context is included.
Inventory per Share over time
Growth rates
- 3-Year CAGR
- +12.1%
- 5-Year CAGR
- +11.9%
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 105This company $6.75 Sector average $30.82
▼
-78.1% below sector average
Key checks
Key Insights
- BioMarin Pharmaceutical's inventory per share has grown for 9 consecutive years.
- In FY2025, inventory per share increased 4.5% year-over-year.
- Ranks #11 out of 105 companies in the Health Care sector.
- Lowest inventory per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Inventory per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.75 | +4.5% |
| FY2024 | $6.46 | +10.1% |
| FY2023 | $5.87 | +22.3% |
| FY2022 | $4.80 | +12.3% |
| FY2021 | $4.27 | +11.2% |
| FY2020 | $3.84 | +1.6% |
| FY2019 | $3.78 | +27.0% |
| FY2018 | $2.98 | +10.1% |
| FY2017 | $2.71 | +31.5% |
| FY2016 | $2.06 | +22.3% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026